Tech Company Financing Transactions

Aura Biosciences Funding Round

Arix Bioscience, Lundbeckfond Ventures and Advent Life Sciences participated in a $30 million Series C funding round for Aura Biosciences. The round was announced on 12/22/2017.

Transaction Overview

Company Name
Announced On
12/22/2017
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series C
Investors

Arix Bioscience (Lead Investor) (Mark Chin)

Lundbeckfond Ventures (Lead Investor) (Casper Breum)

Advent Life Sciences (Dale Pfost)

Alexandria Venture Investments

Chiesi Ventures

Columbus Venture Partners

Private Investors (Henri Termeer)

LI-COR Biosciences

Ysios Capital

Proceeds Purpose
The company plans to use proceeds from this round of financing to expand infrastructure supporting ongoing clinical development.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
85 Bolton St.
Cambridge, MA 02140
USA
Email Address
Overview
Aura Biosciences is developing a new class of therapies to target and selectively destroy tumor cells. Its lead program in ocular melanoma, developed under a CRADA with the National Cancer Institute (NCI), has been granted orphan drug status by the US Food and Drug Administration.
Profile
Aura Biosciences LinkedIn Company Profile
Social Media
Aura Biosciences Company Twitter Account
Company News
Aura Biosciences News
Facebook
Aura Biosciences on Facebook
YouTube
Aura Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Elisabet de los Pinos
  Elisabet de los Pinos LinkedIn Profile  Elisabet de los Pinos Twitter Account  Elisabet de los Pinos News  Elisabet de los Pinos on Facebook
Chief Financial Officer
Julie Feder
  Julie Feder LinkedIn Profile  Julie Feder Twitter Account  Julie Feder News  Julie Feder on Facebook
Chief Medical Officer
Cadmus Rich
  Cadmus Rich LinkedIn Profile  Cadmus Rich Twitter Account  Cadmus Rich News  Cadmus Rich on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/22/2017: FLX Bio venture capital transaction
Next: 12/22/2017: conDati venture capital transaction

 

Share this article

 


Where The Data Comes From

We record all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary